Dose-Titration Study of Sevelamer Carbonate in Chronic Kidney Disease (CKD) Patients on Hemodialysis
Status:
Completed
Trial end date:
2010-09-01
Target enrollment:
Participant gender:
Summary
The study aims to evaluate the efficacy and safety of sevelamer carbonate in reducing serum
phosphorus and serum lipids (total and LDL-cholesterol) in Chronic Kidney Disease Patients on
dialysis.